conduritol a

Conduritol A has a hypoglycemic effect, can have an effect on regulating the metabolism of blood lipid, free-radical scavenging, enhancing the antioxidant ability, potentiating immune function; it also can markedly prevent the diabetic rats from getting c

Conduritol B epoxide (CBE) is a mechanism-directed, irreversible, covalent β-glucosidase inhibitor (IC₅₀ = 1 μM) with weak α-glucosidase inhibitory activity (IC₅₀ = 100 μM). Conduritol B epoxide can be used in research on the mechanisms of lysosomal storage disorders and neurodegenerative diseases.

Conduritol B tetraacetate is a type of biochemical reagent employed in glycobiology research. This field examines the structure, synthesis, biology, and evolution of sugars, encompassing carbohydrate chemistry, glycan formation and degradation enzymatics, protein-glycan recognition, and the role of glycans in biological systems. It is closely linked to fundamental research, biomedicine, and biotechnology.